Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Min-Ke He

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2022
Reply to J. Mei et alMin-Ke He, Qi-Jiong Li, Zhi-Cheng Lai, et al.
Cancer Cell International|September 14, 2019
NAP1L1 is a prognostic biomarker and contribute to doxorubicin chemotherapy resistance in human hepatocellular carcinomaYong Le, Anna Kan, Qi-Jiong Li, et al.
Cancer Cell International|November 19, 2021
Construction of a single nucleotide variant score-related gene-based prognostic model in hepatocellular carcinoma: analysis of multi-independent databases and validation in vitroYu-Jie Xu, Min-Ke He, Shuang Liu, et al.
Chinese Journal of Cancer|October 25, 2017
Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized studyMin-Ke He, Yong Le, Qi-Jiong Li, et al.
Oncology Letters|February 14, 2018
Prognostic significance of sodium-potassium ATPase regulator, FXYD3, in human hepatocellular carcinomaLi-Juan Wang, Qi-Jiong Li, Yong Le, et al.
Oncology Letters|June 22, 2018
Matrix metalloproteinase 12 expression is associated with tumor FOXP3<sup>+</sup> regulatory T cell infiltration and poor prognosis in hepatocellular carcinomaMin-Ke He, Yong Le, Yong-Fa Zhang, et al.
Cancer Medicine|October 12, 2018
Aberrant MCT4 and GLUT1 expression is correlated with early recurrence and poor prognosis of hepatocellular carcinoma after hepatectomyHai-Long Chen, Han-Yue OuYang, Yong Le, et al.
Journal of Cancer|February 6, 2019
Transarterial Chemoembolization related to Good Survival for Selected Patients with advanced Hepatocellular CarcinomaYong Le, Jing-Xian Shen, Yong-Fa Zhang, et al.
Cardiovascular and Interventional Radiology|January 13, 2018
Phase II Study of Sorafenib Combined with Concurrent Hepatic Arterial Infusion of Oxaliplatin, 5-Fluorouracil and Leucovorin for Unresectable Hepatocellular Carcinoma with Major Portal Vein ThrombosisMin-Ke He, Ru-Hai Zou, Qi-Jiong Li, et al.
Cell Death & Disease|November 25, 2023
DNA methylation-activated full-length EMX1 facilitates metastasis through EMX1-EGFR-ERK axis in hepatocellular carcinomaDong-Sheng Wen, Li-Chang Huang, Xiao-Yun Bu, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2022
Reply to J. Mei et alMin-Ke He, Qi-Jiong Li, Zhi-Cheng Lai, et al.
Cancer Cell International|September 14, 2019
NAP1L1 is a prognostic biomarker and contribute to doxorubicin chemotherapy resistance in human hepatocellular carcinomaYong Le, Anna Kan, Qi-Jiong Li, et al.
Cancer Cell International|November 19, 2021
Construction of a single nucleotide variant score-related gene-based prognostic model in hepatocellular carcinoma: analysis of multi-independent databases and validation in vitroYu-Jie Xu, Min-Ke He, Shuang Liu, et al.
Chinese Journal of Cancer|October 25, 2017
Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized studyMin-Ke He, Yong Le, Qi-Jiong Li, et al.
Oncology Letters|February 14, 2018
Prognostic significance of sodium-potassium ATPase regulator, FXYD3, in human hepatocellular carcinomaLi-Juan Wang, Qi-Jiong Li, Yong Le, et al.
Oncology Letters|June 22, 2018
Matrix metalloproteinase 12 expression is associated with tumor FOXP3<sup>+</sup> regulatory T cell infiltration and poor prognosis in hepatocellular carcinomaMin-Ke He, Yong Le, Yong-Fa Zhang, et al.
Cancer Medicine|October 12, 2018
Aberrant MCT4 and GLUT1 expression is correlated with early recurrence and poor prognosis of hepatocellular carcinoma after hepatectomyHai-Long Chen, Han-Yue OuYang, Yong Le, et al.
Journal of Cancer|February 6, 2019
Transarterial Chemoembolization related to Good Survival for Selected Patients with advanced Hepatocellular CarcinomaYong Le, Jing-Xian Shen, Yong-Fa Zhang, et al.
Cardiovascular and Interventional Radiology|January 13, 2018
Phase II Study of Sorafenib Combined with Concurrent Hepatic Arterial Infusion of Oxaliplatin, 5-Fluorouracil and Leucovorin for Unresectable Hepatocellular Carcinoma with Major Portal Vein ThrombosisMin-Ke He, Ru-Hai Zou, Qi-Jiong Li, et al.
Cell Death & Disease|November 25, 2023
DNA methylation-activated full-length EMX1 facilitates metastasis through EMX1-EGFR-ERK axis in hepatocellular carcinomaDong-Sheng Wen, Li-Chang Huang, Xiao-Yun Bu, et al.
Pageof 2